IBDEI1RK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31537,1,3,0)
 ;;=3^Gonococcal Cystitis & Urethritis,Unspec
 ;;^UTILITY(U,$J,358.3,31537,1,4,0)
 ;;=4^A54.01
 ;;^UTILITY(U,$J,358.3,31537,2)
 ;;=^5000312
 ;;^UTILITY(U,$J,358.3,31538,0)
 ;;=B37.49^^190^1939^11
 ;;^UTILITY(U,$J,358.3,31538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31538,1,3,0)
 ;;=3^Candidiasis Urogenital,Other
 ;;^UTILITY(U,$J,358.3,31538,1,4,0)
 ;;=4^B37.49
 ;;^UTILITY(U,$J,358.3,31538,2)
 ;;=^5000618
 ;;^UTILITY(U,$J,358.3,31539,0)
 ;;=B37.41^^190^1939^10
 ;;^UTILITY(U,$J,358.3,31539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31539,1,3,0)
 ;;=3^Candidal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,31539,1,4,0)
 ;;=4^B37.41
 ;;^UTILITY(U,$J,358.3,31539,2)
 ;;=^5000616
 ;;^UTILITY(U,$J,358.3,31540,0)
 ;;=B37.42^^190^1939^9
 ;;^UTILITY(U,$J,358.3,31540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31540,1,3,0)
 ;;=3^Candidal Balanitis
 ;;^UTILITY(U,$J,358.3,31540,1,4,0)
 ;;=4^B37.42
 ;;^UTILITY(U,$J,358.3,31540,2)
 ;;=^5000617
 ;;^UTILITY(U,$J,358.3,31541,0)
 ;;=A59.03^^190^1939^92
 ;;^UTILITY(U,$J,358.3,31541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31541,1,3,0)
 ;;=3^Trichomonal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,31541,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,31541,2)
 ;;=^5000349
 ;;^UTILITY(U,$J,358.3,31542,0)
 ;;=E87.6^^190^1939^53
 ;;^UTILITY(U,$J,358.3,31542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31542,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,31542,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,31542,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,31543,0)
 ;;=F52.0^^190^1939^52
 ;;^UTILITY(U,$J,358.3,31543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31543,1,3,0)
 ;;=3^Hypoactive Sexual Desire Disorder
 ;;^UTILITY(U,$J,358.3,31543,1,4,0)
 ;;=4^F52.0
 ;;^UTILITY(U,$J,358.3,31543,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,31544,0)
 ;;=F52.22^^190^1939^89
 ;;^UTILITY(U,$J,358.3,31544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31544,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,31544,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,31544,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,31545,0)
 ;;=F52.8^^190^1939^90
 ;;^UTILITY(U,$J,358.3,31545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31545,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,31545,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,31545,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,31546,0)
 ;;=F52.21^^190^1939^30
 ;;^UTILITY(U,$J,358.3,31546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31546,1,3,0)
 ;;=3^Erectile Disorder,Male
 ;;^UTILITY(U,$J,358.3,31546,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,31546,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,31547,0)
 ;;=I12.9^^190^1939^51
 ;;^UTILITY(U,$J,358.3,31547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31547,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,31547,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,31547,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,31548,0)
 ;;=N04.9^^190^1939^68
 ;;^UTILITY(U,$J,358.3,31548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31548,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,31548,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,31548,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,31549,0)
 ;;=N02.9^^190^1939^46
 ;;^UTILITY(U,$J,358.3,31549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31549,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,31549,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,31549,2)
 ;;=^5015520
